Interactions of nanoparticles with pulmonary structures and cellular responses

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 5, 2008, Pages

  Mühlfeld, Christian ^a   Rothen Rutishauser, Barbara ^a   Blank, Fabian ^a   Vanhecke, Dimitri ^a   Ochs, Matthias ^a   Gehr, Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Electron tomography; Engineered nanoparticles; Oxidative stress; Translocation; Ultrafine particles

Indexed keywords

NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SURFACTANT;

COMBUSTION; EPITHELIUM CELL; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG STRUCTURE; OXIDATIVE STRESS; PARTICULATE MATTER; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; ANIMAL; CYTOLOGY; DRUG DELIVERY SYSTEM; EXPOSURE; HUMAN; LUNG ALVEOLUS; METABOLISM; RESPIRATORY TRACT MUCOSA;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INHALATION EXPOSURE; NANOPARTICLES; OXIDATIVE STRESS; PULMONARY ALVEOLI; RESPIRATORY MUCOSA;

EID: 45849152063     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00442.2007     Document Type: Review

References (152)

1. Abdelmohsen K, Gerber PA, von Montfort C, Sies H, Klotz LO. Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J Biol Chem 278: 38360-38367, 2003.
2. Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99: 12617-12621, 2002.
3. Albrecht C, Borm PJA, Unfried K. Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles. Mutat Res 553: 59-65, 2004.
4. Alessandrini F, Schulz H, Takenaka S, Lentner B, Karg E, Behrendt H, Jakob T. Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J Allergy Clin Immunol 117: 824-830, 2006.
5. Arredouani M, Yang Z, Ning YY, Qin G, Soininen R, Tryggvason K, Kobzik L. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med 19: 267-272, 2004.
6. Aufderheide M, Mohr U. CULTEX - an alternative technique for cultivation and exposure of cells of the respiratory tract to airborne pollutants at the air/liquid interface. Exp Toxicol Pathol 52: 265-270, 2000.
7. Aufderheide M. Direct exposure methods for testing native atmospheres. Exp Toxicol Pathol 57: 213-226, 2005.
8. Azzazy HME, Mansour MMH, Kazmierczak SC. From diagnostics to therapy: prospects of quantum dots. Clin Biochem 40: 917-927, 2007.
9. Bakshi MS, Zhao L, Smith R, Possmayer F, Petersen NO. Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. Biophys J 94: 855-868, 2008.
10. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, Semmler M, Takenaka S, Stettmaier K, Bors W, Ghio A, Samet JM, Heyder J. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 38: 1080-1092, 2005.
11. Bermudez LE, Sangari FJ, Kolonoski P, Petrofsky M, Goodman J. The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect Immun 70: 140-146, 2002.
12. Bhalla DK, Mannix RC, Kleinman MT, Crocker TT. Relative permeability of nasal, tracheal, and bronchoalveolar mucosa to macromolecules in rats exposed to ozone. J Toxicol Environ Health 17: 269-283, 1986.
13. Birkness KA, Deslauriers M, Bartlett JH, White EH, King CH, Quinn FD. An in vitro tissue culture bilayer model to examine early events in Mycobacterium tuberculosis infection. Infect Immun 67: 653-658, 1999.
14. Bitterle E, Karg E, Schroeppel A, Kreyling W, Tippe A, Ferron GA, Schmid O, Heyder J, Maier KL, Hofer T. Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles. Chemosphere 65: 1784-1790, 2006.
15. Blank F, Rothen-Rutishauser B, Schurch S, Gehr P. An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 19: 392-405, 2006.
16. Blank F, Rothen-Rutishauser B, Gehr P. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 36: 669-677, 2007.
17. Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 1: 255-277, 2004.
18. Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 120: 1325-1373, 1979.
19. Brain JD, Blanchard JD. Deposition and fate of inhaled pharmacological aerosols. In: Provocation Testing in Clinical Practice, edited by Spector SL. New York: Marcel Dekker, 1995.
20. Brown DM, Donaldson K, Borm PJ, Schins RP, Dehnhardt M, Gilmour P, Jimenez LA, Stone V. Calcium and ROS-mediated activation of transcription factors and TNF-α cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 286: L344-L353, 2004.
21. Brown DM, Hutchison L, Donaldson K, Stone V. The effects of PM10 particles and oxidative stress on macrophages and lung epithelial cells: modulating effects of calcium-signaling antagonists. Am J Physiol Lung Cell Mol Physiol 292: L1444-L1451, 2007.
22. Chang LY, Crapo JD. Quantitative evaluation of minimal injuries. In: Models of Lung Disease. Microscopy and Structural Methods, edited by Gil J. New York: Marcel Dekker, 1990.
23. Chen HW, Su SF, Chien CT, Lin WH, Yu SL, Chou CC, Chen JJW, Yang PC. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J 20: E1732-E1741, 2006.
24. Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 265: 49-72, 2002.
25. De Haar C, Hassing I, Bol M, Bleumink R, Pieters R. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin Exp Allergy 36: 1469-1479, 2006.
26. De Kok TM, Driece HA, Hogervorst JG, Briedé JJ. Toxicological assessment of ambient and traffic-related particulate matter: a review of recent studies. Mutat Res 613: 103-122, 2006.
27. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2: 10, 2005.
28. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 92: 5-22, 2006.
29. Eaton M. Nanomedicine: industry-wise research. Nat Mater 6: 251-253, 2007.
30. Erpenbeck VJ, Malherbe DC, Sommer S, Schmiedl A, Steinhilber W, Ghio AJ, Krug N, Wright JR, Hohlfeld JM. Surfactant protein D increases phagocytosis and aggregation of pollen-starch granules. Am J Physiol Lung Cell Mol Physiol 288: L692-L698, 2005.
31. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22: 969-976, 2004.
32. Gardner DE, Kennedy GL. Methodologies and technology for animal inhalation toxicology studies. In: Toxicology of the Lung (2nd ed.), edited by Gardner DE, Crapo JD, McClellan RO. New York: Raven, 1993.
33. Gehr P, Bachofen M, Weibel ER. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol 32: 121-140, 1978.
34. Gehr P, Schürch S, Berthiaume Y, Im Hof V, Geiser M. Particle retention in airways by surfactant. J Aerosol Med 3: 27-43, 1990.
35. Gehr P, Geiser M, Stone KC, Crapo JD. Morphometric analysis of the gas exchange region of the lung. In: Toxicology of the Lung (2nd ed.), edited by Gardner DE, Crapo JD, McClellan RO. New York: Raven, 1993.
36. Geiser M. Morphological aspects of particle uptake by lung phagocytes. Microsc Res Tech 57: 512-522, 2002.
37. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs, and in cultured cells. Environ Health Perspect 113: 1555-1560, 2005.
38. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol. In press.
39. Gerber PJ, Lehmann C, Gehr P, Schürch S. Wetting and spreading of a surfactant film on solid particles: influence of sharp edges and surface irregularities. Langmuir 22: 5273-5281, 2006.
40. Gonzalez-Flecha B. Oxidant mechanisms in response to ambient air particles. Mol Aspects Med 25: 169-182, 2004.
41. Green FHY, Gehr P, Lee MM, Schürch S. The role of surfactant in disease associated with particle exposure. In: Particle-Lung Interactions, edited by Gehr P, Heyder J. New York: Marcel Dekker, 2000.
42. Gwinn MR, Vallyathan V. Nanoparticles: health effects - pros and cons. Environ Health Perspect 114: 1818-1825, 2006.
43. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph node metastases in prostate cancer. N Engl J Med 348: 2491-2499, 2003.
44. Heyder J, Gebhart J, Rudolf G, Schiller CF, Stahlofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J Aerosol Sci 17: 811-825, 1986.
45. Hinds WC. Aerosol Technology (2nd ed.). New York: John Wiley & Sons, 1999.
46. Hoshino A, Fujioka K, Oku T, Nakamura S, Suga M, Yamaguchi Y, Suzuki K, Yasuhara M, Yamamoto K. Quantum dots targeted to the assigned organelle in living cells. Microbiol Immunol 48: 985-994, 2004.
47. Hughes K, Antonsson A, Grundstrom T. Calmodulin dependence of NF-κB activation. FEBS Lett 441: 132-136, 1998.
48. Huh YM, Jun YW, Song HT, Kim S, Choi JS, Lee JH, Yoon S, Kim KS, Shin JS, Suh JS, Cheon J. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 127: 12387-12391, 2005.
49. Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA. Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8: 1038-1044, 2002.
50. John AE, Lukacs NW, Berlin AA, Palecanda A, Bargatze RF, Stoolman LM, Nagy JO. Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease. FASEB J 17: 2296-2298, 2003.
51. Johnston CJ, Finkelstein JN, Mercer P, Corson N, Gelein R, Oberdörster G. Pulmonary effects induced by ultrafine PTFE particles. Toxicol Appl Pharmacol 168: 208-215, 2000.
52. Jones BG, Dickinson PA, Gumbleton M, Kellaway IW. Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383. J Pharm Pharmacol 54: 1065-1072, 2002.
53. Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y. Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res 41: 615-626, 2007.
54. Kanno S, Furuyama A, Hirano S. A murine scavenger receptor MARCO recognizes polystyrene nanoparticles. Toxicol Sci 97: 398-406, 2007.
55. Kapp N, Kreyling W, Schulz H, Im Hof V, Gehr P, Semmler M, Geiser M. Electron energy loss spectroscopy for analysis of inhaled ultrafine particles in rat lungs. Microsc Res Tech 63: 298-305, 2004.
56. Kendall M. Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage. Am J Physiol Lung Cell Mol Physiol 293: L1053-L1508, 2007.
57. Kim HR, Andrieux K, Gil S, Taverna M, Chacun H, Desmaele D, Taran F, Georgin D, Couvreur P. Translocation of poly (ethylene glycol-co-hexadecyl) cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. Biomacromolecules 8: 793-799, 2007.
58. Kim JS, Yoon TJ, Yu KN, Noh MS, Woo M, Kim BG, Lee KH, Sohn BH, Park SB, Lee JK, Cho MH. Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells. J Vet Sci 7: 321-326, 2006.
59. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, Parker JA, Mihaljevic T, Laurence RG, Dor DM, Cohn LH, Bawendi MG, Frangioni JV. Near infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22: 93-97, 2004.
60. Kim YM, Reed W, Lenz AG, Jaspers I, Silbajoris R, Nick HS, Samet JM. Ultrafine carbon particles induce interleukin-8 gene transcription and p38 MAPK activation in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 288: L432-L441, 2005.
61. Kipen HM, Laskin DL. Smaller is not always better: nanotechnology yields nanotoxicology. Am J Physiol Lung Cell Mol Physiol 289: L696-L697, 2005.
62. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 111: 476-494, 2006.
63. Klotz LO. Oxidant-induced signalling: effects of peroxynitrite and singlet oxygen. Biol Chem 383: 443-456, 2002.
64. Kooter IM, Boere AJF, Fokkens PHB, Leseman DLAC, Dormans JAMA, Cassee FR. Response of spontaneously hypertensive rats to inhalation of fine and ultrafine particles from traffic: experimental controlled study. Part Fibre Toxicol 3: 7, 2006.
65. Kremer JR, Mastronarde DN, McIntosh JR. Computer visualization of three-dimensional image data using IMOD. J Struct Biol 116: 71-76, 1996.
66. Kreyling W, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65: 1513-1530, 2002.
67. Kumagai Y, Arimoto T, Shinyashiki M, Shimojo N, Nakai Y, Yoshikawa T, Sagai M. Generation of reactive oxygen species during interaction of diesel exhaust particle components with NADPH-cytochrome P450 reductase and involvement of the bioactivation in the DNA damage. Free Radic Biol Med 22: 479-487, 1997.
68. Kumar M, Kong X, Behera AK, Hellermann GR, Lockey RF, Mohapatra SS. Chitosan IFN-gamma-pDNA nanoparticle (CIN) therapy for allergic asthma. Genet Vaccines Ther 1: 3, 2003.
69. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111: 455-460, 2003.
70. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. Oxide nanoparticle uptake in human fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 39: 9370-9376, 2005.
71. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 41: 4158-4163, 2007.
72. Livadaru L, Kovalenko A. Fundamental mechanism of translocation across liquidlike membranes: toward control over nanoparticle behavior. Nano Lett 6: 78-83, 2006.
73. Lundborg M, Johard U, Lastbom L, Gerde P, Camner P. Human alveolar macrophage phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ Res 86: 244-253, 2001.
74. Lundborg M, Dahlen SE, Johard U, Gerde P, Jarstrand C, Camner P, Lastbom L. Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages. Environ Res 100: 197-204, 2006.
75. Lundborg M, Bouhafs R, Gerde P, Ewing P, Camner P, Dahlén SE, Jarstrand C. Aggregates of ultrafine particles modulate lipid peroxidation and bacterial killing by alveolar macrophages. Environ Res 104: 250-257, 2007.
76. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB. Safe handling of nanotechnology. Nature 444: 267-269, 2006.
77. McClellan RO. Particle interactions with the respiratory tract. In: Particle-Lung Interactions, edited by Gehr P, Heyder J. New York: Marcel Dekker, 2000.
78. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 109: 707-712, 2002.
79. Meiring JJ, Borm PJA, Bagate K, Semmler M, Seitz J, Takenaka S, Kreyling WG. The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol 2: 3, 2005.
80. Micha JP, Goldstein BH, Birk CL, Rettenmaier MA, Brown JV 3rd. Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions. Gynecol Oncol 100: 437-438, 2006.
81. Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM, Cassee FR, Boon NA, MacNee W, Millar AM, Donaldson K, Newby DE. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 173: 426-431, 2006.
82. Morin JP, Preterre D, Keravec V, Thuillez C. Rotating wall vessel as a new in vitro shear stress generation system: application to rat coronary endothelial cell cultures. Cell Biol Toxicol 19: 227-242, 2003.
83. Mornet S, Vasseur S, Grasset F, Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 14: 2161-2175, 2004.
84. Mossman BT, Lounsbury KM, Reddy SP. Oxidants and signalling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell Mol Biol 34: 666-669, 2006.
85. Mühlfeld C, Mayhew TM, Gehr P, Rothen-Rutishauser B. A novel quantitative method for analysing the distributions of nanoparticles between different tissue and intracellular compartments. J Aerosol Med, 20: 395-407, 2007.
86. Mühlfeld C, Geiser M, Kapp N, Gehr P, Rothen-Rutishauser B. Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the "relative deposition index": evidence for clearance through microvasculature. Part Fibre Toxicol 4: 7, 2007.
87. Mühlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, Ochs M. Visualization and quantitative analysis of nanoparticles in the respiratory system by transmission electron microscopy. Part Fibre Toxicol 4: 11, 2007.
88. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 207: 221-231, 2005.
89. Murthy SK. Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomed 2: 129-141, 2007.
90. Muttil P, Kaur J, Kumar K, Yadav AB, Sharma R, Misra A. Inhalable microparticles containing payload of anti-tuberculosis drugs. Eur J Pharm Sci 32: 140-150, 2007.
91. Nemmar A, Hoet PHM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation 105: 411-414, 2002.
92. Nemmar A, Hamoir J, Nemery B, Gustin P. Evaluation of particle translocation across the aveolo-capillary barrier in isolated perfused rabbit lung model. Toxicology 208: 105-113, 2004.
93. Nemmar A, Hoylaerts MF, Hoet PHM, Nemery B. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett 149: 243-253, 2004.
94. Nicod L. Pulmonary defence mechanisms. Respiration 66: 2-11, 1999.
95. Oberdörster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102: 173-179, 1994.
96. Oberdörster G. Kinetics of inhaled ultrafine particles in the organism. In: Effects of Air Contaminants on the Respiratory Tract - Interpretation From Molecules to Meta Analysis, edited by Heinrich U. INIS Monograph. Stuttgart, Germany: Fraunhofer, 2004.
97. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies on ultrafine particles. Environ Health Perspect 113: 823-839, 2005.
98. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H; ILSI. Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Work Group: principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2: 8, 2005.
99. Ochs M. A brief update on lung stereology. J Microsc 222: 188-200, 2006.
100. Ochs M. Stereological analysis of acute lung injury. Eur Respir Rev 15: 115-121, 2006.
101. Ottensmeyer FP. Elemental mapping by energy filtration: advantages, limitations, and compromises. Ann NY Acad Sci 483: 339-353, 1986.
102. Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly (D,L-lactide-co-glycolide) nanoparticles. Int J Pharm 262: 1-11, 2003.
103. Patil S, Sandberg A, Heckert E, Self W, Seal S. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28: 4600-4607, 2007.
104. Pauluhn J, Mohr U. Inhalation studies in laboratory animals - current concepts and alternatives. Toxicol Pathol 28: 734-753, 2000.
105. Pauluhn J. Overview of inhalation exposure techniques: strengths and weaknesses. Exp Toxicol Pathol 57: 111-128, 2005.
106. Penn A, Murphy G, Barker S, Henk W, Penn L. Combustion-derived ultrafine particles transport organic toxicants to target respiratory cells. Environ Health Perspect 113: 956-963, 2005.
107. Pison U, Welte T, Giersig M, Groneberg DA. Nanomedicine for respiratory diseases. Eur J Pharmacol 533: 341-350, 2006.
108. Porter AE, Muller K, Skepper J, Midgley P, Welland M. Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. Acta Biomater 2: 409-419, 2006.
109. Pourazar J, Mudway IS, Samet JM, Helleday R, Blomberg A, Wilson SJ, Frew AJ, Kelly FJ, Sandstrom T. Diesel exhaust activates redox-sensitive transcription factors and kinases in human airways. Am J Physiol Lung Cell Mol Physiol 289: L724-L730, 2005.
110. Pulskamp K, Diabaté S, Krug HF. Carbon nanotubes show no signs of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 168: 58-74, 2007.
111. Qiao R, Roberts AP, Mount AS, Klaine SJ, Ke PC. Translocation of C60 and its derivatives across a lipid bilayer. Nano Lett 7: 614-619, 2007.
112. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39: 56-63, 2004.
113. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 61: 442-447, 2004.
114. Rimai DS, Quesnel DJ, Busnaia AA. The adhesion of dry particles in the nanometer to micrometer -size range. Colloids Surf A Physicochem Eng Asp 165: 3-10, 2000.
115. Ritter D, Knebel JW, Aufderheide M. Exposure of human lung cells to inhalable substances: a novel test strategy involving clean air exposure periods using whole diluted cigarette mainstream smoke. Inhal Toxicol 15: 67-84, 2003.
116. Rossin R, Muro S, Welch MJ, Muzykantov VR, Schuster DP. In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med 49: 103-111, 2008.
117. Rothen-Rutishauser B, Kiama SG, Gehr P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 32: 281-289, 2005.
118. Rothen-Rutishauser BM, Schürch S, Haenni B, Kapp N, Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 40: 4353-4359, 2006.
119. Rothen-Rutishauser B, Schürch S, Gehr P. Interaction of particles with membranes. In: Toxicology of Particles, edited by Donaldson K, Borm P. Boca Raton, FL: CRC, 2007.
120. Rothen-Rutishauser Mühlfeld C, Blank F, Musso C, Gehr P. Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol 4: 9, 2007.
121. Salvador-Morales C, Townsend P, Flahaut E, Vénien-Bryan C, Vlandas A, Green MLH, Sim RB. Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms. Carbon 45: 607-617, 2007.
122. Schins RP, Knaapen AM. Genotoxicity of poorly soluble particles. Inhal Toxicol 19, Suppl 1: 189-198, 2007.
123. Schubert D, Dargusch R, Raitano J, Chan SW. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 342: 86-91, 2006.
124. Schulz H, Brand P, Heyder J. Particle deposition in the respiratory tract. In: Particle-Lung Interactions, edited by Gehr P, Heyder J. New York: Marcel Dekker, 2000.
125. Schürch S, Gehr P, Im Hof V, Geiser M, Green F. Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 80: 17-32, 1990.
126. Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdörster G, Kreyling WG. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect 115: 728-733, 2007.
127. Sharma CS, Sarkar S, Periyakaruppan A, Barr J, Wise K, Thomas R, Wilson BL, Ramesh GT. Single-walled carbon nanotubes induces oxidative stress in rat lung epithelial cells. J Nanosci Nanotechnol 7: 2466-2472, 2007.
128. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001.
129. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21: 10644-10654, 2005.
130. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289: L698-L708, 2005.
131. Singh S, Shi T, Duffin R, Albrecht C, van Verlo D, Höhr D, Fubini B, Martra G, Fenoglio I, Borm PJA, Schins RPF. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharmacol 222: 141-151, 2007.
132. Stearns R, Paulauskis JD, Godleski JJ. Endocytosis of ultrafine particles by A549 cells. Am J Respir Cell Mol Biol 24: 108-115, 2001.
133. Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect 114: 328-333, 2006.
134. Sydlik U, Bierhals K, Soufi M, Abel J, Schins RP, Unfried K. Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using EGF-R. Am J Physiol Lung Cell Mol Physiol 291: L725-L733, 2006.
135. Takenaka S, Karg E, Kreyling WG, Lentner B, Möller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, Heyder J, Schulz H. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 18: 733-740, 2006.
136. Tamaoki J, Isono K, Takeyama K, Tagaya E, Nakata J, Nagai A. Ultrafine carbon black particles stimulate proliferation of human airway epithelium via EGF-R. Am J Physiol Lung Cell Mol Physiol 287: L1127-L1133, 2004.
137. Tarkington BK, Wu R, Sun WM, Nikula KJ, Wilson DW, Last JA. In vitro exposure of tracheobronchial epithelial cells and of tracheal explants to ozone. Toxicology 88: 51-68, 1994.
138. Tippe A, Heinzmann U, Roth C. Deposition of fine and ultrafine aerosol particles during exposure at the air/cell interface. J Aerosol Sci 33: 207-218, 2002.
139. Tsai YY, Oca-Cossio J, Agering K, Simpson NE, Atkinson MA, Wasserfall CH, Constantinidis I, Sigmund W. Novel synthesis of cerium oxide nanoparticles for free radical scavenging. Nanomed 2: 325-332, 2007.
140. Tseng CL, Wang TW, Dong GC, Wu SY, Young TH, Shieh MJ, Lou PJ, Lin FH. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 28: 3996-4005, 2007.
141. Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G. Cellular uptake and toxicity of Au55 clusters. Small 8-9: 841-844, 2005.
142. Unfried K, Albrecht C, Klotz LO, von Mikecz A, Grether-Beck S, Schins RPF. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1: 1-20, 2007.
143. Veranth JM, Kaser EG, Veranth MM, Koch M, Yost GS. Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre Toxicol 4: 2, 2007.
144. Voisin C, Aerts C, Jakubczak E, Houdret JL, Tonnel TB. Effects of nitrogen dioxide on alveolar macrophages surviving in the gas phase. A new experimental model for the study of in vitro cytotoxicity of toxic gases. Bull Eur Physiopathol Respir 13: 137-144, 1977.
145. Voisin C, Aerts C, Jakubczak E, Tonnel AB. La culture cellulaire en phase gazeuse. Un nouveau modele experimental d'etude in vitro des activites des macrophages alveolaires [in French]. Bull Eur Physiopathol Respir 13: 69-82, 1977.
146. Weibel ER, Hsia CC, Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 102: 459-467, 2007.
147. Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Möller W, Sommerer K, Larsson Svartengren M. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J 28: 286-290, 2006.
148. Wilson MR, Lightbody JH, Donaldson K, Sales J, Stone V. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol Appl Pharmacol 184: 172-179, 2002.
149. Wright JG, Christman JW. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: Implications for therapy. Am J Respir Med 2: 211-219, 2003.
150. Xia T, Korge P, Weiss JN, Li N, Venkatesen MI, Sioutas C, Nel A. Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: implications for ultrafine particle toxicity. Environ Health Perspect 112: 1347-1358, 2004.
151. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6: 1794-1807, 2006.
152. Yacobi NR, Phuleria HC, Demaio L, Liang CH, Peng CA, Sioutas C, Borok Z, Kim KJ, Crandall ED. Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties. Toxicol In Vitro 21: 1373-1381, 2007.